Eligard 30 mg

Eligard 30 mg is a sustained-release powder for suspension used for hormone-related conditions. This subcutaneous injection contains leuprolide acetate and is manufactured by Tolmar International Ltd. in Ireland.

Eligard 30 mg is primarily used for conditions requiring hormone regulation, such as prostate cancer. This medication works by reducing the production of certain hormones in the body. It is often prescribed for long-term management of specific health issues related to hormone levels.

Common effects of Eligard 30 mg may include temporary discomfort at the injection site, hot flashes, and changes in bone density. Some users may experience fatigue or mood changes. These effects vary and are not exhaustive; individual responses can differ.

Eligard 30 mg should be handled with care, ensuring proper storage and administration by a healthcare professional. It is important to discuss any existing medical conditions or allergies with your healthcare provider before use. Follow all safety guidelines provided with the medication.

Eligard 30 mg may interact with other medications, including those that affect hormone levels or blood clotting. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with this medication.